Cargando…

Withaferin A protects against hyperuricemia induced kidney injury and its possible mechanisms

The study was designed to explore the effects of Withaferin A (WFA) on hyperuricemia-induced kidney injury and its action mechanism. Potassium oxonate (PO) was employed to establish the hyperuricemic mouse model. The pathological changes of renal tissue were evaluated by hematoxylin-eosin and masson...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xia, Wang, Jing, Tang, Liying, Li, Pei, Ru, Jing, Bai, Yuzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806220/ https://www.ncbi.nlm.nih.gov/pubmed/33517833 http://dx.doi.org/10.1080/21655979.2021.1882761

Ejemplares similares

Withaferin A inhibits ferroptosis and protects against intracerebral hemorrhage
por: Zhou, Zi-Xian, et al.
Publicado: (2022)

Withaferin A protects against spinal cord injury by inhibiting apoptosis and inflammation in mice
por: Yan, Xianlei, et al.
Publicado: (2017)

Association between hyperuricemia and acute kidney injury in critically ill patients with sepsis
por: Jiang, Yuan-Xia, et al.
Publicado: (2023)

Ameliorative effect of cheqianzi decoction on hyperuricemia and kidney injury and underlying mechanism in rats
por: Meng, Jing, et al.
Publicado: (2023)

Casein Kinase 2-Interacting Protein-1 Alleviates High Glucose-Reduced Autophagy, Oxidative Stress, and Apoptosis in Retinal Pigment Epithelial Cells via Activating the p62/KEAP1/NRF2 Signaling Pathway
por: Zhao, Xia, et al.
Publicado: (2021)

oxLDL-mediated cellular senescence is associated with increased NADPH oxidase p47phox recruitment to caveolae
por: Wang, Jing, et al.
Publicado: (2018)

Withaferin A Induces Oxidative Stress-Mediated Apoptosis and DNA Damage in Oral Cancer Cells
por: Chang, Hsueh-Wei, et al.
Publicado: (2017)

Withaferin A Protects against Primary and Recurrent Tuberculosis by Modulating Mycobacterium-Specific Host Immune Responses
por: Kumari, Anjna, et al.
Publicado: (2023)

Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives
por: Behl, Tapan, et al.
Publicado: (2020)

A rare case report of reversible acute kidney injury due to hyperuricemia alone
por: Zhang, Yan, et al.
Publicado: (2021)

Implications of Withaferin A in neurological disorders
por: Ram, Natasha, et al.
Publicado: (2020)

Withaferin A: a potential therapeutic agent against COVID-19 infection
por: Straughn, Alex R., et al.
Publicado: (2020)

Hyperuricemia is accompanied by elevated peripheral CD4(+) T cells
por: Yu, Qiuyang, et al.
Publicado: (2023)

Urinary Proteomic Characteristics of Hyperuricemia and Their Possible Links with the Occurrence of Its Concomitant Diseases
por: Huo, Shuai, et al.
Publicado: (2021)

Withaferin A activates TRIM16 for its anti-cancer activity in melanoma
por: Nagy, Zsuzsanna, et al.
Publicado: (2020)

Characteristics of hyperuricemia in older adults in China and possible associations with sarcopenia
por: Xu, Zhe‐rong, et al.
Publicado: (2018)

Withaferin A protects against palmitic acid-induced endothelial insulin resistance and dysfunction through suppression of oxidative stress and inflammation
por: Batumalaie, Kalaivani, et al.
Publicado: (2016)

Admission hyperuricemia increases the risk of acute kidney injury in hospitalized patients(*)
por: Cheungpasitporn, Wisit, et al.
Publicado: (2016)

Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia
por: Pan, Libin, et al.
Publicado: (2020)

Influence of hyperuricemia treatment on postoperative acute kidney injury among hyperuricemia patients: a single-center retrospective database analysis
por: Watanabe, Shinichiro, et al.
Publicado: (2019)

Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
por: Kielstein, Jan T., et al.
Publicado: (2020)

Withaferin A alleviates fulminant hepatitis by targeting macrophage and NLRP3
por: Xia, Yangliu, et al.
Publicado: (2021)

Hyperuricemia, the heart, and the kidneys – to treat or not to treat?
por: Petreski, Tadej, et al.
Publicado: (2020)

Withaferin-A—A Natural Anticancer Agent with Pleitropic Mechanisms of Action
por: Lee, In-Chul, et al.
Publicado: (2016)

Withaferin A Associated Differential Regulation of Inflammatory Cytokines
por: Dubey, Seema, et al.
Publicado: (2018)

Evaluation of the geroprotective effects of withaferin A in Drosophila melanogaster
por: Koval, Liubov, et al.
Publicado: (2021)

Loss of DEPTOR in renal tubules protects against cisplatin-induced acute kidney injury
por: Wang, Caixia, et al.
Publicado: (2018)

Research Advances in the Mechanisms of Hyperuricemia-Induced Renal Injury
por: Su, Hong-yong, et al.
Publicado: (2020)

Role of Withaferin A and Its Derivatives in the Management of Alzheimer’s Disease: Recent Trends and Future Perspectives
por: Das, Rajib, et al.
Publicado: (2021)

Allopurinol for prevention of progression of kidney disease with hyperuricemia
por: Pai, B. H. Santhosh, et al.
Publicado: (2013)

The grey zone of Hyperuricemia in chronic kidney disease
por: Dousdampanis, Periklis
Publicado: (2017)

Hyperuricemia and chronic kidney disease: to treat or not to treat
por: Piani, Federica, et al.
Publicado: (2021)

Screening the Best Compatibility of Selaginella moellendorffii Prescription on Hyperuricemia and Gouty Arthritis and Its Mechanism
por: Zhang, Xue-yan, et al.
Publicado: (2019)

Hyperuricemia increases the risk of acute kidney injury: a systematic review and meta-analysis
por: Xu, Xialian, et al.
Publicado: (2017)

Kidney Diseases Enhance Expression of Tetraspanin-8: A Possible Protective Effect against Tubular Injury
por: Hirukawa, Takashi, et al.
Publicado: (2014)

Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo
por: Yang, Huanjie, et al.
Publicado: (2012)

Withaferin A attenuates ovarian cancer-induced cardiac cachexia
por: Kelm, Natia Q., et al.
Publicado: (2020)

Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology
por: Dutta, Rinku, et al.
Publicado: (2019)

Estimation of Withaferin-A by HPLC and standardization of the Ashwagandhadi lehyam formulation
por: Meena, Ajay Kumar, et al.
Publicado: (2021)

Withaferin A: From Ancient Remedy to Potential Drug Candidate
por: Sultana, Tahira, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_35nqfqvai1vbsc9qirgdie4egd